




Int. J. Environ. Res. Public Health 2021, 18, 5865. https://doi.org/10.3390/ijerph18115865 www.mdpi.com/journal/ijerph 
Article 
Incidence, Risk Factors, and Outcomes of Preterm and Early 
Term Births: A Population-Based Register Study 
Salma Younes 1, Muthanna Samara 2, Rana Al-Jurf 3, Gheyath Nasrallah 3, Sawsan Al-Obaidly 4, Husam Salama 5, 
Tawa Olukade 5, Sara Hammuda 2, Mohamed A. Ismail 1, Ghassan Abdoh 5, Palli Valapila Abdulrouf 1,6,  
Thomas Farrell 1,4, Mai AlQubaisi 5, Hilal Al Rifai 5 and Nader Al-Dewik 1,3,7,8,9,10,* 
1 Department of Research, Women’s Wellness and Research Center, Hamad Medical Corporation,  
Doha 3050, Qatar; V-SYounes@hamad.qa (S.Y.); MISMAIL4@hamad.qa (M.A.I.);  
PABDULROUF@hamad.qa (P.V.A.); TFarrell@hamad.qa (T.F.) 
2 Department of Psychology, Kingston University London, Kingston upon Thames, London KT1 2EE, UK;  
M.Samara@kingston.ac.uk (M.S.); sarahammuda@hotmail.com (S.H.) 
3 Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, 
Doha 2713, Qatar; 199660690@student.qu.edu.qa (R.A.-J.); gheyath.nasrallah@qu.edu.qa(G.N.) 
4 Obstetrics and Gynecology Department, Women’s Wellness and Research Center, Hamad Medical Corpora-
tion, Doha 3050, Qatar; Salobaidly@hamad.qa 
5 Department of Pediatrics and Neonatology, Neonatal Intensive Care Unit, Newborn Screening Unit, 
Women’s Wellness and Research Center, Hamad Medical Corporation, Doha 3050, Qatar;  
hsalama1@hamad.qa (H.S.); TOlukade@hamad.qa (T.O.); Gabdoh@hamad.qa (G.A.); 
MALQUBAISI@hamad.qa (M.A.); Halrifai@hamad.qa  (H.A.R.) 
6 Department of Pharmacy, Women’s Wellness and Research Center, Hamad Medical Corporation,  
Doha 3050, Qatar 
7 Interim Translational Research Institute (iTRI), Hamad Medical Corporation (HMC) Doha 3050, Qatar 
8 Faculty of Health and Social Care Sciences, Kingston University, St. George’s University of London,  
London KT1 2EE, UK 
9 Clinical and Metabolic Genetics, Department of Pediatrics, Hamad General Hospital, Hamad Medical  
Corporation, Doha 3050, Qatar 
10 College of Health and Life Science (CHLS), Hamad Bin Khalifa University (HBKU), Doha 34110, Qatar 
* Correspondence: Naldewik@hamad.qa or Nader.Al-Dewik@kingston.ac.uk; Tel.: +974-44395191 or  
+974-55481107; Fax: +00974-44395161 
Abstract: Preterm birth (PTB) and early term birth (ETB) are associated with high risks of perinatal 
mortality and morbidity. While extreme to very PTBs have been extensively studied, studies on 
infants born at later stages of pregnancy, particularly late PTBs and ETBs, are lacking. In this study, 
we aimed to assess the incidence, risk factors, and feto-maternal outcomes of PTB and ETB births in 
Qatar. We examined 15,865 singleton live births using 12-month retrospective registry data from 
the PEARL-Peristat Study. PTB and ETB incidence rates were 8.8% and 33.7%, respectively. PTB 
and ETB in-hospital mortality rates were 16.9% and 0.2%, respectively. Advanced maternal age, pre-
gestational diabetes mellitus (PGDM), assisted pregnancies, and preterm history independently 
predicted both PTB and ETB, whereas chromosomal and congenital abnormalities were found to be 
independent predictors of PTB but not ETB. All groups of PTB and ETB were significantly associ-
ated with low birth weight (LBW), large for gestational age (LGA) births, caesarean delivery, and 
neonatal intensive care unit (NICU)/or death of neonate in labor room (LR)/operation theatre (OT). 
On the other hand, all or some groups of PTB were significantly associated with small for gestational 
age (SGA) births, Apgar <7 at 1 and 5 minutes and in-hospital mortality. The findings of this study 
may serve as a basis for taking better clinical decisions with accurate assessment of risk factors, 
complications, and predictions of PTB and ETB. 
Keywords: preterm birth (PTB), prematurity; late preterm birth (Late PTB), early term birth (ETB), 
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Preterm birth (PTB) is considered the main cause of perinatal mortality and morbid-
ity in industrialized countries [1]. Many PTB-born children who survive face adverse 
short-term and long-term consequences, including behavioral. health related quality of 
life, cognitive, eating and neurological impairments, and chronic conditions, which in 
some cases, can lead to death [2–8]. 
In the past, a pregnancy that lasted anywhere between 37 and 42 weeks was referred 
to as a term pregnancy [9,10]. However, driven by the growing body of evidence that 
significant differences exist in the outcomes of infants delivered within this 5-week inter-
val, the definitions for term pregnancies have been updated [9,11]. In 2013, a full-term 
pregnancy (FTB) has been redefined as a pregnancy that lasts between 39 weeks, 0 days 
and 40 weeks 6 days, whereas the period between 37 weeks to 38 weeks, 6 days of gesta-
tion is now referred to as early term birth (ETB) [9,11]. PTBs are not the only gestational 
age (GA) subgroup at risk of adverse clinical outcomes [12,13]. Recent evidence suggests 
that ETBs are associated with high risk of mortality, more admissions to neonatal inten-
sive care units [13], as well as conferring a high risk for respiratory diseases and neuro-
logical disabilities [14]. 
Over the past 20 years, the rate of PTB has been escalating steadily and alarmingly. 
Of 65 countries around the world, all but three countries have shown an increase in PTB 
rates over the past two decades [1]. The estimated global PTB rate in 2014 was 10.6%, 
corresponding to approximately ~14.8 million live preterm births, of which ~12 million 
(81.1%) occurred in Asia and sub-Saharan Africa [15]. Over 75% of all perinatal mortality 
and 50% of perinatal and long-term morbidities are associated with PTBs [16,17]. ETBs are 
more common than PTBs, with international prevalence rates ranging from 15% to 30% 
[18,19]. In developed countries, the pooled rate of ETBs in in the period 2006–2014 was 
estimated to range from 16.8% in Finland to 26.9% in the USA [18]. However, the propor-
tion of ETBs in many developing countries remains unclear. Thus, there is a lack of evi-
dence concerning the impact of ETB on maternal and neonatal outcomes. 
 PTBs and ETBs are believed to involve both genetic and environmental factors. 
Causal factors linked to PTB include medical conditions [20], genetic influences [21–23], 
environmental exposure [24,25], infertility treatments [26,27], as well as behavioral and 
socioeconomic factors [28–30]. While extreme to very PTBs have been extensively studied, 
and the associated morbidities are well-documented [31–33], studies on infants born at 
later stages of pregnancy, particularly late PTBs and ETBs, are lacking. Thus, in this pop-
ulation-based study, we aimed to assess the incidence of PTB and ETB over a period of 12 
months in Qatar, and examine the associated neonatal and maternal risk factors, as well 
as the feto-maternal consequences in the perinatal-neonatal period. 
2. Materials and Methods 
2.1. Study Design and Data Collection 
This study is a 12-month retrospective population-based study conducted using reg-
istry data from the PEARL-Peristat Study, Qatar. This population-based registry was de-
signed using routinely collected hospital data for parturient women and their offspring. 
The study was approved by the Hamad Medical Corporation (HMC) Institutional Review 
Board (IRB), with a waiver of consent. 
We included singleton live births at 24+0 weeks gestation and above, whose mothers 
delivered between April 2017 and March 2018 at the Women’s Wellness and Research 
Centre (WWRC) in HMC, the main national hospital and provider of secondary and ter-
tiary health care facilities in Qatar. Stillbirths were excluded, as there was no certainty of 
the presence or absence of PTBs. Out of 15,872 identified singleton births, gestational age 
was missing for 7 infants and thus these were excluded. Finally, a total of 15,865 singleton 
births were examined. 
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2.2. Neonatal Factors 
Gestational age was classified into preterm and term births; preterm births were fur-
ther categorized into extremely to very PTB (< 32 weeks), moderate PTB (32 to < 34 weeks), 
and late PTB (34 to < 37 weeks). Moreover, in accordance with established international 
definitions [12], we further discriminated between ETB (37 to < 39) and FTB (39 to < 42). 
Baby gender was categorized into male, female, and ambiguous. Birth weight was 
categorized as low and normal (≤ 2499g and ≥ 2500g, respectively). In addition, appropri-
ate for gestational age (AGA), small for gestational age (SGA), and large for gestational 
age (LGA) were defined as those with estimated fetal weight between 10th percentile and 
90th percentile, below the 10th percentile, or above the 90th percentile, respectively. Low 
Apgar scores at 1 min and at 5 min were defined as any score lower than 7 [34]. Baby 
outcome was categorized into discharged alive or in-hospital mortality, while baby dis-
position was categorized into postnatal ward and Neonatal Intensive Care Unit (NICU) 
or death in Labor Room/ Operation Theatre (LR/OT). 
2.3. Maternal Factors  
Maternal age was categorised into young (< 20 years), normal (20–34 years), ad-
vanced (35–39 years), very advanced (40–44 years), and extremely advanced (≥ 45 years) 
age ranges. Parity was classified into nulliparous or parity ≥ 1. Nationality was grouped 
into Qatari (n: 4941, 32%), other Arabs based on the UNESCO list of Arab countries (n: 
6306, 40%), and other nationalities (Asian: n: 3711, 23%; Europeans and North and South 
Americans: n: 151, 1%; others: n: 752, 4%). Consanguinity was coded as yes (the mother 
and the father are related to each other in any level of relatedness) or no. Educational level 
was grouped into three categories including elementary and below, secondary school or 
high school, and college/university or above. Employment status was categorised into em-
ployed or unemployed. History of PTB and history of smoking were coded as yes versus 
no. To reduce selection bias from PTB history variable, we excluded women who were 
marked as having a history of multiple birth from this variable. The risk of PTB is higher 
with multiple pregnancies. 
Women were categorized according to their glycemic status into diabetic and non-
diabetic, and further categorized into pregestational diabetics (PGDM), gestational dia-
betics (GDM), and non-diabetics (no data on Type 1 or 2 were recorded). Chronic hyper-
tension was coded as yes or no. Women were also categorized into obese and non-obese 
using pre-pregnancy and the first 12 weeks of pregnancy (pre- and early-pregnancy; PP 
obesity) BMI. This was determined by calculating the BMI during that period, calculated 
from height and weight. The variable was then categorized into non-obese (< 30 kg/m2) 
and obese (BMI ≥ 30 kg/m2) following NHLBI/WHO guidelines [35,36]. 
Pregnancy mode was defined as spontaneous or assisted (including ovulation induc-
tion, invitro fertilisation, intracytoplasmic sperm injection, intra uterine insemination, and 
others). Delivery mode was categorized into vaginal and caesarean. 
2.4. Statistical Analysis 
Statistical analysis using IBM SPSS 26 software (SPSS, Chicago IL, USA) was con-
ducted. All categorical and binary variables were reported as numbers and percentages. 
The overall incidence of PTB and ETB, risk factors, and outcomes were analyzed using 
Chi-Square analysis on the differences between each PTB and ETB groups in one hand 
and FTB on the other hand. Regression analyses were performed in two stages. Risk fac-
tors associated with PTB and ETB were examined and the associations with the outcomes 
were quantified; they were reported as odds ratios (OR) and 95% confidence intervals 
(CI). 
In stage one, we used univariate logistic regression to investigate the association of 
maternal and neonatal risk factors with PTBs and ETBs in comparison to FTB. Multiple 
logistic regression was then performed including the significant variables with p < 0.05 
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from the univariate analysis. PP obesity was excluded from the multiple logistic regres-
sion due to missing values. In stage two, univariate logistic regression was performed to 
investigate the association of PTBs and ETBs in comparison with FTB as predictors of sev-
eral neonatal and maternal outcomes. After that multiple logistic regression was per-
formed adjusting for the variables that were significant from the univariate analysis at the 
first stage. The independent risk factors included in the final model were reported as ORs 
and 95% CIs. Statistical significance was defined as p < 0.05. 
3. Results 
3.1. Characteristics of the Study Population and Differences between pre and early Term Groups 
in Comparison to Full Term Group. 
A total of 15,872 singleton live births registered in the PEARL database from April 
2017 to March 2018 were identified, of which 15,865 singleton live births were examined 
(Figure 1, Table S1). 
The maternal characteristics and newborn distribution of the overall study popula-
tion are shown in Table 1. Table 1 shows the differences between each PTB and ETB group 
in comparison to FTB in relation to each demographic and medical variable. PTB and ETB 
incidence rates were 8.8% and 33.7%, respectively. In-hospital mortality was 16.9% among 
PTB infants and 0.2% among ETB infants (Table 1, Table S1). 
 
Figure 1. Flow chart of the study live births: term and preterm numbers and percentages. 
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Table 1. Characteristics of the study population according to gestational age groups: differences between each PTB and 
ETB group in comparison to FTB in relation to various demographic and medical variables. 
  
Extreme to Very 
PTB (n = 214) 
Moderate PTB  
(n = 160) 
Late PTB  
(n = 1015) 
ETB 





n (%) p Value n (%) p Value n (%) p Value n (%) p Value n (%) 
Maternal age   < 0.001   < 0.001   < 0.001   < 0.001   
Normal (20–34 yr) 149 (69.6)  
107 





Young (< 20 yr) 5 (2.3)  7 (4.4)  20 (2)  99 (1.9)  219 (2.4) 
Advanced (35–39 yr) 46 (21.5)  36 (22.5)  217 (21.4)  937 (17.5)  1209 
(13.2) 
Very advanced (40–44 yr) 14 (6.5)  9 (5.6)  53 (5.2)  310 (5.8)  285 (3.1) 
Extremely advanced (≥ 45 
yr) 0 (0)  1 (0.6)  7 (0.7)  29 (0.5)  13 (0.1) 
Parity  0.001  0.283  0.105  < 0.001  
Nulliparous 85 (39.7)  53 (33.1)  272 (26.8)  1232 (23)  
2668 
(29.2) 




 743 (73.2)  4116 (77)  6460 
(70.8) 
Nationality   < 0.05  < 0.05  < 0.001  0.001  














Consanguineous  0.161  0.651  0.163  0.634  





Yes 14 (25)  16 (37.2)  131 (37.6)  717 (33.3)  
1255 
(33.9) 
Education  0.570  0.168  < 0.05  0.248  
Elementary and below 4 (6.5)  1 (2.2)  47 (12.4)  205 (9)  355 (8.9) 
Secondary/Highschool 23 (37.1)  12 (26.7)  130 (34.3)  673 (29.5)  1254 (31.5) 





Diabetes status  < 0.001  < 0.001  < 0.001  < 0.001  








GDM 43 (20.1)  48 (30)  348 (34.3)  1829 (34.2)  2099 (23) 
PGDM 10 (4.7)  9 (5.6)  54 (5.3)  260 (4.9)  48 (0.5) 





 982 (96.7)  5243 (98)  9078 
(99.5) 
Yes 9 (4.2)  11 (6.9)  33 (3.3)  105 (2)  50 (0.5) 
PP obesity  < 0.05  0.529  < 0.001  < 0.001  
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No 43 (58.9)  33 (67.3)  262 (62.7)  1403 (63.4)  
2369 
(71.4) 
Yes 30 (41.1)  16 (32.7)  156 (37.3)  811 (36.6)  947 (28.6) 
Baby gender  < 0.01  < 0.05  < 0.001  < 0.001  
Male 125 
(58.4) 








Ambiguous 0 (0)  0 (0)  1 (0.1)  1 (0)  0 (0) 
Chromosomal/congenital 
abnormality 









Yes 29 (13.6)  12 (7.5)  47 (4.6)  77 (1.4)  96 (1.1) 










Yes 4 (2.6)  2 (1.6)  8 (1.1)  32 (0.8)  56 (0.8) 









Yes 42 (19.6)  30 (18.8)  155 (15.3)  453 (8.5)  370 (4.1) 
Employment status  0.477  0.346  0.357  0.151  





Unemployed 0 (0)  1 (2.3)  5 (1.4)  29 (1.3)  35 (0.9) 
Birth weight  < 0.001  < 0.001  < 0.001  < 0.001  
≤ 2499g 210 (98.6)  
148 
(92.5)  432 (42.6)  375 (7)  127 (1.4) 
≥ 2500g 3 (1.4)  12 (7.5)  583 (57.4)  4972 (93)  
8996 
(98.6) 
Fetal weight by GA  < 0.001  < 0.001  < 0.001  < 0.001  
AGA 120 
(56.3) 




SGA 41 (19.2)  28 (17.5)  112 (11)  250 (4.7)  451 (5.7) 
LGA 52 (24.4)  36 (22.5)  221 (21.8)  971 (18.2)  
1002 
(12.7) 





 961 (95.1)  5159 (97)  8906 
(98.1) 
Assisted 12 (5.6)  9 (5.7)  49 (4.9)  157 (3)  169 (1.9) 
Delivery mode  < 0.001  < 0.001  < 0.001  < 0.001  















 956 (94.5)  5280 (99)  8975 
(98.6) 
Yes 99 (46.9)  20 (12.7)  56 (5.5)  56 (1)  131 (1.4) 
Apgar <7 at 5 min  < 0.001  < 0.001  < 0.001  0.251  
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No 196 (92.9)  
154 





Yes 15 (7.1)  3 (1.9)  10 (1)  9 (0.2)  9 (0.1) 
Baby outcome  < 0.001  < 0.001  < 0.001  0.052  










In-hospital mortality 24 (11.2)  7 (4.4)  13 (1.3)  13 (0.2)  10 (0.1) 
Baby disposition  < 0.001  < 0.001  < 0.001  < 0.001  





NICU or death in LR/OT 
213 
(99.5)   152 (95)   375 (36.9)   494 (9.2)   600 (6.6) 
Abbreviations: Ref, reference group; PTB, preterm birth; ETB, early term birth; DM, diabetes mellitus; GDM, gestational 
diabetes mellitus; PGDM, pre-gestational diabetes mellitus; PP, pre- and early-pregnancy; AGA, appropriate for gesta-
tional age; SGA, small for gestational age; LGA, large for gestational age; Apgar, appearance, pulse, grimace, activity, and 
respiration; NICU, neonatal intensive care unit; LR, labour room; OT, operation theatre. Bold values denote statistically 
significant differences between each PTB and ETB group in one hand and FTB on the other hand. 
3.2. Risk Factors Associated with PTB and ETB. 
The regression analysis shows that for extreme to very PTB, advanced maternal age 
(aOR, 1.81; 95% CI, 1.15–2.83), very advanced maternal age (aOR, 2.39; 95% CI, 1.12–5.11), 
parity ≥ 1 (aOR, 0.34; 95% CI, 0.23–0.51), PGDM (aOR, 7.37; 95% CI, 2.97–18.31), chromo-
somal/congenital abnormalities (aOR, 15.52; 95% CI, 8.91–27.02), history of preterm birth 
(aOR, 7.23; 95% CI, 4.44–11.77), and assisted pregnancy (aOR, 2.49; 95% CI, 1.19–5.21) were 
found to be independent predictors in the univariate and the multivariate analyses (Table 
2, Table S2). However, ethnic group, chronic hypertension, baby gender, and smoking 
history status became non-significant in the adjusted model (Table 2, Table S2). 
Table 2. Multivariate regression analyses of the risk factors associated with PTB and ETB. 
Risk Factors 
Extreme to Very 
PTB 
(n = 214) 
Moderate PTB  
(n = 160) 
Late PTB 
(n = 1015) 
ETB 
(n = 5348) 
aOR a (95%CI) aOR b (95%CI) aOR c (95%CI) aOR d (95%CI) 
Maternal age     
Normal (20–34 
yr) 
ref ref ref ref 
Young (< 20 yr) 0.96 (0.34–2.72) 2.76 (1.26–6.07) ‡ 1.01 (0.48–2.13) 1.02 (0.8–1.31) 
Advanced (35–
39 yr) 








NA 1.64 (0.16–16.9) 4.97 (0.79–31.38) 2.36 (1.18–4.71) ‡ 
Parity     
Nulliparous ref   ref 
Parity ≥ 1 0.34 (0.23–0.51) *   1.21 (1.11–1.32) * 
Nationality      
Qataris 0.78 (0.51–1.2) 0.87 (0.59–1.28) 0.8 (0.61–1.05) 0.99 (0.9–1.08) 
Other Arabs 0.73 (0.48–1.09) 0.6 (0.4–0.89) ‡ 0.64 (0.49–0.83) * 0.89 (0.81–0.96) † 




Nationalities ref ref ref ref 
Education     
Elementary 
and below   
1.46 (1.02–2.08) ‡  
Secondary/Hi
ghschool 
  1.25 (0.98–1.59)  
University or 
above   ref  
Diabetes status     
No DM ref ref ref ref 











hypertension     
No ref ref ref ref 
Yes 2.97 (0.96–9.18) 6.5 (2.92–14.46) * 1.14 (0.37–3.49) 2.39 (1.67–3.43) * 
Baby gender     
Female ref ref ref ref 




    




7.9 (4.14–15.04) * 3.9 (1.97–7.7) * 1.26 (0.92–1.72) 
Smoking     
No ref    
Yes 3.01 (0.99–9.13)    
Preterm history     




4.7 (3.04–7.28) * 3.5 (2.48–4.94) * 1.95 (1.68–2.26) * 
Pregnancy mode     
Spontanious 
pregnancy ref ref ref ref 
Assisted 
pregnancy 
2.49 (1.19–5.21) ‡ 2.82 (1.38–5.79) † 3.11 (1.9–5.08) * 1.61 (1.28–2.02)* 
Abbreviations: cOR, crude odds ratio; aOR, adjusted odds ratio; CI, confidence interval; Ref, refer-
ent; NA, not applicable; PTB, preterm birth; ETB, early term birth; DM, diabetes mellitus; GDM, 
gestational diabetes mellitus; PGDM, pre-gestational diabetes mellitus; PP, pre- and early-preg-
nancy; AGA, appropriate for gestational age; SGA, small for gestational age; LGA, large for gesta-
tional age; Apgar, appearance, pulse, grimace, activity, and respiration; NICU, neonatal intensive 
care unit; LR, labor room; OT, operation theatre. Bold values denote statistical significance at the * 
p < 0.001, † p < 0.01 and ‡ p < 0.05. a adjusted for maternal age, parity, nationality, diabetes status, 
chronic hypertension, baby gender, chromosomal/congenital abnormalities, smoking, preterm 
history, and pregnancy mode. b adjusted for maternal age, nationality, diabetes status, chronic 
hypertension, baby gender, chromosomal/congenital abnormalities, preterm history, and preg-
nancy mode. c adjusted for maternal age, nationality, education status, diabetes status, chronic 
hypertension, baby gender, chromosomal/congenital abnormalities, preterm history, and preg-
nancy mode. d adjusted for maternal age, parity, nationality, diabetes status, chronic hypertension, 
baby gender, chromosomal/congenital abnormalities, preterm history, and pregnancy mode. 
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Notes: Only variables which showed significant results in the univariate analysis were included in 
the multiple logistic regression analysis, and presented in this table. PP obesity was exceptionally 
excluded from the multiple logistic regression, although significant in univariate analysis, due to 
missing values. 
For moderate PTB, young maternal age (aOR, 2.76; 95% CI, 1.26–6.07), other Arab 
nationalities (aOR, 0.6; 95% CI, 0.4–0.89), GDM (aOR, 1.47; 95% CI, 1.03–2.1), PGDM (aOR, 
5.03; 95% CI, 2.08–12.17), chronic hypertension (aOR, 6.5; 95% CI, 2.92–14.46), chromoso-
mal/congenital abnormalities (aOR, 7.9; 95% CI, 4.14–15.04), assisted pregnancy (2.82; 95% 
CI, 1.38–5.79), preterm history (aOR, 4.7; 95% CI, 3.04–7.28), and male baby gender (aOR, 
1.46; 95% CI, 1.06–2.03) were found to be significant predictors in the univariate and the 
multivariate analyses (Table 2, Table S2). However, mothers with advanced (35–39 years) 
and very advanced (40–44 years) ages became non-significant after adjustment (Table 2, 
Table S2). 
For late PTB, advanced maternal age (aOR, 1.39; 95% CI, 1.05–1.86), other Arab na-
tionalities (aOR, 0.64; 95% CI, 0.49–0.83), level of education of elementary and below (aOR, 
1.46; 95% CI, 1.02–2.08), GDM (aOR, 1.61; 95% CI, 1.27–2.05), PGDM (aOR, 6.55; 95% CI, 
3.17–13.52), chromosomal/congenital abnormalities (aOR, 3.9; 95% CI, 1.97–7.70), preterm 
history (aOR, 3.5; 95% CI, 2.48–4.94), and assisted delivery (aOR, 3.11; 95% CI, 1.90–5.08) 
were found to be independent predictors in the univariate and the multivariate analyses 
(Table 2, Table S2). However, advanced maternal age (35-39 years), extremely advanced 
maternal age (≥ 45 years), chronic hypertension, and male gender became non-significant 
in the adjusted model (Table 2, Table S2). 
For ETB, advanced maternal age (aOR, 1.18; 95% CI, 1.07–1.31), very advanced ma-
ternal age (aOR, 1.53; 95% CI, 1.28–1.82), extremely advanced maternal age (aOR, 2.36; 
95% CI, 1.18–4.71), parity ≥ 1 (aOR, 1.21; 95% CI, 1.11–1.32), other Arab nationalities (aOR, 
0.89; 95% CI, 0.81–0.96), GDM (aOR, 1.8; 95% CI, 1.67–1.94), PGDM (aOR, 9.72; 95% CI, 
7.07–13.35), chronic hypertension (aOR, 2.39; 95% CI, 1.67–3.43), male babies (1.2; 95% CI, 
1.11–1.28), preterm history (aOR, 1.95; 95% CI, 1.68–2.26), and assisted pregnancies (aOR, 
1.61; 95% CI, 1.28–2.02) were found to be independent predictors in the univariate and the 
multivariate analyses (Table 2, Table S2). However, chromosomal/congenital abnormali-
ties became non-significant in the adjusted model (Table 2, Table S2). 
3.3. Adverse Outcomes Associated with PTB and ETB 
Extreme to very PTB significantly predicted all assessed outcomes; LBW (aOR, 
5669.36; 95% CI, 1317.88–24388.98), SGA (aOR, 4.11; 95% CI, 2.55–6.64), LGA (aOR, 3.8; 
95% CI, 2.5–5.79), caesarean delivery (aOR, 5.26; 95% CI, 3.71–7.47), low Apgar <7 at 1 min 
(aOR, 52.3; 95% CI, 33.89–80.71) and at 5 min (aOR, 69.2; 95% CI, 20.54–233.09), in-hospital 
mortality (aOR, 84.73; 95% CI, 28.87–248.69), and NICU/death in LR/OT (aOR, 2417.24; 
95% CI, 332.79–17557.67) in the univariate and the adjusted models (Table 3, Table S3). 
Table 3. Multivariate regression analysis of the pregnancy and feto-maternal outcomes associated with PTB and ETB. 
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Abbreviations: cOR, crude odds ratio; aOR, adjusted odds ratio; CI, confidence interval; Ref, referent; NA, not applicable; 
PTB, preterm birth; ETB, early term birth; DM, diabetes mellitus; GDM, gestational diabetes mellitus; PGDM, pre-gesta-
tional diabetes mellitus; AGA, appropriate for gestational age; SGA, small for gestational age; LGA, large for gestational 
age; Apgar, Appearance, Pulse, Grimace, Activity, and Respiration; NICU, neonatal intensive care unit; LR, labor room; 
OT, operation theatre. Bold values denote statistical significance at the * p < 0.001, † p < 0.01 and ‡ p < 0.05. a adjusted for 
maternal age, parity, nationality, diabetes status, chronic hypertension, baby gender, chromosomal/congenital abnormal-
ities, smoking, preterm history, and pregnancy mode. b adjusted for maternal age, nationality, diabetes status, chronic 
hypertension, baby gender, chromosomal/congenital abnormalities, preterm history, and pregnancy mode. c adjusted for 
maternal age, nationality, education status, diabetes status, chronic hypertension, baby gender, chromosomal/congenital 
abnormalities, preterm history, and pregnancy mode. d adjusted for maternal age, parity, nationality, diabetes status, 
chronic hypertension, baby gender, chromosomal/congenital abnormalities, preterm history, and pregnancy mode. 
Moderate PTB significantly predicted all assessed outcomes; LBW (aOR, 1021.64; 95% 
CI, 520.79–2004.19), SGA (aOR, 3.78; 95% CI, 2.38–6.00), LGA (aOR, 2.44; 95% CI, 1.63–
3.64), caesarean delivery (aOR, 4.54; 95% CI, 3.26–6.34), low Apgar <7 at 1 min (aOR, 7.73; 
95% CI, 4.43–13.50) and at 5 min (aOR, 9.81; 95% CI, 2.01–47.91), in-hospital mortality 
(aOR, 27.76; 95% CI, 7.52–102.48), and NICU/death in LR/OT (aOR, 274.38; 95% CI, 132.59–
567.78) in the univariate and the adjusted models (Table 3, Table S3). 
Late PTB significantly predicted LBW (aOR, 57.41; 95% CI, 40.1–82.19), SGA (aOR, 
1.9; 95% CI, 1.28–2.82), LGA (aOR, 1.87; 95% CI, 1.39–2.5), caesarean delivery (aOR, 2.47; 
95% CI, 1.96–3.12), and NICU/death in LR/OT (aOR, 8.48; 95% CI, 6.37–11.28) in the uni-
variate and the adjusted models. However, low Apgar < 7 at 1 min and at 5 min, and in-
hospital mortality became non-significant after adjustment (Table 3, Table S3). 
ETB significantly predicted LBW (aOR, 5.96; 95% CI, 4.83–7.35), LGA (1.37; 95% CI, 
1.24–1.52), caesarean delivery (aOR, 2.14; 95% CI, 1.98–2.32), Apgar < 7 at 1 min (aOR, 0.71; 
95% CI, 0.51–0.99), and NICU/death in LR/OT (aOR, 1.31; 95% CI, 1.15–1.51) in the uni-
variate and the adjusted models. However, low Apgar < 7 at 5 min, and in-hospital mor-
tality became non-significant after adjustment (Table 3, Table S3). 
4. Discussion 
Our population-based study showed a PTB incidence of 88 per 1000 total singleton 
births (8.8%), and ETB incidence was estimated to be 337 per 1000 total singleton births 
(33.7%), between April 2017 and March 2018. Several factors were shared among the dif-
ferent gestational age groups, including advanced maternal age, PGDM, assisted delivery, 
and preterm history, which conferred a relatively higher risk for PTB and ETB in compar-
ison to FTB (Table 2, Table S2). In-hospital mortality was highest within the extreme to 
very PTB (11.2%) group in comparison to the other PTB groups (moderate: 4.4%; late: 
1.3%). Not only PTB, but also ETB was significantly associated with higher rates of cae-
sarean deliveries, LBW, LGA, and admission to NICU/or death in LR/OT. 
The estimated incidence for PTB (8.8%) is higher than that reported in Qatar back in 
2014 (4.48%, UI: 3.02–6.42) [16], comparable to that reported in Europe, and Latin America 
and the Caribbean (8.8% and 9.8%, respectively) [11], yet, it is lower than that reported in 
North America (11.2%), Northern Africa (13.4%), Oceania (10.0%), and Sub-Saharan Af-
rica (12.0%) [11]. In regard to ETB, there is a dearth of epidemiological studies assessing 
the incidence, risk factors, and outcomes to be able to establish valid comparisons [37]. 
In this study, advanced maternal age, PGDM, assisted delivery, and preterm history 
were independent predictors of both PTB and ETB (Table 2, Table S2). These are all well-
established risk factors for PTB and ETBs among different racial and ethnic groups 
[21,22,38,39]. Mothers with chromosomal or congenital abnormalities were more likely to 
deliver PTB but not ETB, after adjusting for the confounding factors. This indicates that 
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the trend of the risk distribution for PTB delivery in mothers with chromosomal or con-
genital abnormalities may differ according to the distribution of gestational age.  
In this study, both PTB and ETB significantly predicted low birth weight, large-for-
gestational-age (LGA) births, caesarean delivery, admission to neonatal intensive care 
unit (NICU), and deaths of neonate in labor room (LR)/or operation theatre (OT) (Table 
3). Globally, PTB complications are the leading cause of mortality among children aged < 
5 years, responsible for an estimated 1 million deaths in 2015 [40]. There are huge geo-
graphical variations in the rates of PTB mortality and absolute number of deaths due to 
complications related to PTBs [41]. As gestational age decreases, mortality rates increase, 
and infants who are both PTB and SGA are at even higher risk [42,43]. In high-income 
countries, advancements in healthcare have helped improve survival and long-term ad-
verse consequences in very and extremely PTB-born children [44]. In developed countries, 
extremely PTB-born infants are estimated to have a 90% survival chance, nevertheless, 
they may suffer long-term neurological, and physical disabilities. On the other hand, only 
10% of extremely PTB-born infants are estimated to survive in low-income countries [45]. 
Despite the consequences and burden caused by these outcomes, most of them can 
be prevented [35]. It is estimated that three-quarters of the global deaths due to PTBs could 
be prevented with current, cost-effective interventions [40]. According to reports from 
high-income countries, it is estimated that most prematurity cases can be offered care that 
could be lifesaving or that would reduce adverse events. It is noteworthy to mention that 
cesarean sections in cases of PTB labor can be protective, but can also lead to significant 
morbidities among both the mothers and their babies, and thus, the ideal delivery mode 
for PTB singletons remains controversial [46]. 
This population-based study was performed using data retrieved from the PEARL-
Peristat Study (Perinatal Neonatal Registry), based on predesigned hospital data pertain-
ing to mothers and newborns [47]. This database is large enough that the sample size is 
representative of births in Qatar [47]. Additionally, since the concept of ETB is a relatively 
new one, this study is one of only a few studies to examine the risk factors and outcomes 
associated with ETB. 
5. Conclusions 
This large population-based study is the first to assess the incidence, risk factors, and 
outcomes associated with PTB and ETB in Qatar and one of the very few studies to assess 
the risk factors and outcomes associated with ETB worldwide. The findings of this study 
may serve as a basis to help make better clinical decisions with accurate assessment of risk 
factors, complications, and realistic predictions related to PTB and ETB, which should ul-
timately provide a way forward for precision health and to help reduce the burden and 
the consequences associated with PTB and ETB. 
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